These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1285416)

  • 21. Effects of tryptophan and/or acute running on extracellular 5-HT and 5-HIAA levels in the hippocampus of food-deprived rats.
    Meeusen R; Thorré K; Chaouloff F; Sarre S; De Meirleir K; Ebinger G; Michotte Y
    Brain Res; 1996 Nov; 740(1-2):245-52. PubMed ID: 8973821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action.
    Fernández-Guasti A; Hong E; López-Rubalcava C
    Psychopharmacology (Berl); 1992; 107(1):61-8. PubMed ID: 1350351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam.
    Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
    Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential anxiolytic properties of R-(+)-8-OSO2CF3-PAT, a 5-HT 1A receptor agonist.
    Barf T; Korte SM; Korte-Bouws G; Sonesson C; Damsma G; Bohus B; Wikström H
    Eur J Pharmacol; 1996 Feb; 297(3):205-11. PubMed ID: 8666051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
    Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
    Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo/ex vivo and behavioural study on central effects of 5-HT1B/1D and 5-HT1A antagonists in guinea pigs.
    Rex A; Voigt JP; Wicke KM; Fink H
    Pharmacol Biochem Behav; 2008 Jan; 88(3):196-204. PubMed ID: 17888505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.
    Sharp T; Bramwell SR; Grahame-Smith DG
    Br J Pharmacol; 1989 Feb; 96(2):283-90. PubMed ID: 2466516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroanatomical site of the inhibitory influence of anxiolytic drugs on central serotonergic transmission.
    Nishikawa T; Scatton B
    Brain Res; 1986 Apr; 371(1):123-32. PubMed ID: 2871894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.
    Sharp T; McQuade R; Bramwell S; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):339-46. PubMed ID: 7904048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that the median raphé nucleus--dorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety.
    Andrews N; File SE; Fernandes C; Gonzalez LE; Barnes NM
    Psychopharmacology (Berl); 1997 Apr; 130(3):228-34. PubMed ID: 9151356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience.
    Canto-de-Souza A; Luiz Nunes-de-Souza R; Rodgers RJ
    Brain Res; 2002 Feb; 928(1-2):50-9. PubMed ID: 11844471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional distribution of extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the brain of freely moving rats.
    Adell A; Carceller A; Artigas F
    J Neurochem; 1991 Feb; 56(2):709-12. PubMed ID: 1703223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus.
    File SE; Gonzalez LE
    Pharmacol Biochem Behav; 1996 May; 54(1):123-8. PubMed ID: 8728549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release.
    Stenfors C; Ross SB
    Psychopharmacology (Berl); 2004 Mar; 172(2):119-28. PubMed ID: 14735290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
    Gomes KS; Nunes-De-Souza RL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1261-9. PubMed ID: 19625008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-methyl-D-aspartate receptors modulate extracellular 5-hydroxytryptamine concentration in rat hippocampus and striatum in vivo.
    Whitton PS; Richards DA; Biggs CS; Fowler LJ
    Neurosci Lett; 1994 Mar; 169(1-2):215-8. PubMed ID: 7519338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats.
    Martin P; Carlsson ML; Hjorth S
    Neuroreport; 1998 Sep; 9(13):2985-8. PubMed ID: 9804302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment.
    Keck ME; Sartori SB; Welt T; Müller MB; Ohl F; Holsboer F; Landgraf R; Singewald N
    J Neurochem; 2005 Mar; 92(5):1170-9. PubMed ID: 15715667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.